|
Federal
Register Notices > Notices - 2006
>
Lipomed Inc.
FR Doc E6-20745 [Federal Register: December 7, 2006 (Volume 71, Number 235)]
[Notices] [Page 70986] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07de06-79]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated July 10, 2006 and published in the Federal Register on July
24, 2006, (71 FR 41837-41838), Lipomed Inc., One Broadway, Cambridge,
Massachusetts 02142, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as an importer of the basic classes of
controlled substances listed in schedule I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
N-Ethylamphetamine (1475)
|
I
|
|
Methaqualone (2565)
|
I
|
| Gamma hydroxybutyric acid
(2010)
|
I
|
| Lysergic acid diethylamide
(7315),
|
I
|
|
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7438)
|
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Mescaline (7381)
|
I
|
| 3,4,5-Trimethoxyamphetamine
(7390)
|
I
|
| 4-Bromo-2,5-dimethoxyamphetamine
(7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
4-Methyl-2,5-dimethoxyamphetamine (7395)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
2,5-Dimethoxy-4-ethylamphetamine (7399)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (7405)
|
I
|
|
4-Methoxyamphetamine (7411)
|
I
|
|
Dimethyltryptamine (7435)
|
I
|
|
Psilocybin (7437)
|
I
|
|
Psilocyn (7438)
|
I
|
|
Acetyldihydrocodeine (9051)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Heroin (9200)
|
I
|
|
Normorphine (9313)
|
I
|
|
Pholcodine (9314)
|
I
|
|
Tilidine (9750)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Amobarbital (2125)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Secobarbital (2315)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Benzoylecgonine (9180)
|
II
|
|
Ethylmorphine (9190)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage forms)(9273)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Fentanyl (9801)
|
II
|
|
Sufentanil (9740)
|
II
|
The company plans to import analytical reference standards for distribution
to its customers for research and analytical purposes.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and
952(a) and determined that the registration of Lipomed
Inc. to import the basic classes of controlled substances is consistent with the
public interest and with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA has
investigated Lipomed Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification of the
company's compliance with State and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and
in accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled substances
listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E6-20745 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
